<VariationArchive RecordType="classified" VariationID="393" VariationName="NM_000405.5(GM2A):c.410del (p.His137fs)" VariationType="Deletion" Accession="VCV000000393" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2016-10-23" MostRecentSubmission="2016-10-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15432" VariationID="393">
      <GeneList>
        <Gene Symbol="GM2A" FullName="ganglioside GM2 activator" GeneID="2760" HGNC_ID="HGNC:4367" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="151253185" stop="151270440" display_start="151253185" display_stop="151270440" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="150632612" stop="150649954" display_start="150632612" display_stop="150649954" Strand="+" />
          </Location>
          <OMIM>613109</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000405.5(GM2A):c.410del (p.His137fs)</Name>
      <CanonicalSPDI>NC_000005.10:151266896:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q33.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="151266897" stop="151266897" display_start="151266897" display_stop="151266897" variantLength="1" positionVCF="151266896" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="150646458" stop="150646458" display_start="150646458" display_stop="150646458" variantLength="1" positionVCF="150646457" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>H137fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.151266897del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.151266897del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001167607.3" sequenceAccession="NM_001167607" sequenceVersion="3" change="c.410del">
            <Expression>NM_001167607.3:c.410del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001161079.1" sequenceAccession="NP_001161079" sequenceVersion="1" change="p.His137fs">
            <Expression>NP_001161079.1:p.His137fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.150646458del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.150646458del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009059.1" sequenceAccession="NG_009059" sequenceVersion="1" change="g.18846del">
            <Expression>NG_009059.1:g.18846del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000405.5" sequenceAccession="NM_000405" sequenceVersion="5" change="c.410del" MANESelect="true">
            <Expression>NM_000405.5:c.410del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000396.2" sequenceAccession="NP_000396" sequenceVersion="2" change="p.His137fs">
            <Expression>NP_000396.2:p.His137fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="613109.0004" DB="OMIM" />
        <XRef Type="rs" ID="2127240813" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000405.5(GM2A):c.410del (p.His137fs) AND Tay-Sachs disease, variant AB" Accession="RCV000000424" Version="3">
        <ClassifiedConditionList TraitSetID="105">
          <ClassifiedCondition DB="MedGen" ID="C0268275">Tay-Sachs disease, variant AB</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1996-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1996-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-10-23" MostRecentSubmission="2016-10-23">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">8900233</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="105" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5205" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Tay-Sachs disease, variant AB</ElementValue>
                <XRef ID="Gm2-gangliosidosis%2C+ab+variant/8491" DB="Genetic Alliance" />
                <XRef ID="71253000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gm2-gangliosidosis, ab variant</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Acute infantile GM2 activator deficiency is a neurodegenerative disorder in which infants, who are generally normal at birth, have progressive weakness and slowing of developmental progress between ages four and 12 months. An ensuing developmental plateau is followed by progressively rapid developmental regression. By the second year of life decerebrate posturing, difficulty in swallowing, and worsening seizures lead to an unresponsive vegetative state. Death usually occurs between ages two and three years.</Attribute>
                <XRef ID="NBK583219" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17406" />
                <XRef ID="17406" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36007105</ID>
                <ID Source="BookShelf">NBK583219</ID>
              </Citation>
              <XRef ID="309246" DB="Orphanet" />
              <XRef ID="C0268275" DB="MedGen" />
              <XRef ID="MONDO:0010099" DB="MONDO" />
              <XRef Type="MIM" ID="272750" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20568" SubmissionDate="2016-10-21" DateLastUpdated="2016-10-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="613109.0004_GM2-GANGLIOSIDOSIS, AB VARIANT" title="GM2A, 1-BP DEL, 410A_GM2-GANGLIOSIDOSIS, AB VARIANT" />
        <ClinVarAccession Accession="SCV000020568" DateUpdated="2016-10-23" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1996-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In the offspring of a consanguineous Spanish mating with GM2-gangliosidosis AB variant (272750), Schepers et al. (1996) identified homozygosity for a single-base deletion at codon 137 (410A) that caused a frameshift in the GM2A gene. The frameshift resulted in substitution of 33 amino acids, the loss of another 24 amino acid residues, and a termination codon at residue 170. Although the cultured fibroblasts of both patients reported by Schepers et al. (1996) produced normal levels of GM2A mRNA, they lacked a lysosomal form of GM2A protein. Pulsed-chase labeling of cultured fibroblasts indicated premature degradation of both the mutant and the truncated GM2A protein in the endoplasmic reticulum or Golgi. These results were supported by in vitro translation experiments and expression of the mutated proteins.</Attribute>
              <Citation>
                <ID Source="PubMed">8900233</ID>
              </Citation>
              <XRef DB="OMIM" ID="272750" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GM2A" />
          </GeneList>
          <Name>GM2A, 1-BP DEL, 410A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 410A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613109.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GM2-GANGLIOSIDOSIS, AB VARIANT</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="20568" TraitType="Disease" MappingType="Name" MappingValue="GM2-GANGLIOSIDOSIS, AB VARIANT" MappingRef="Preferred">
        <MedGen CUI="C0268275" Name="Tay-Sachs disease, variant AB" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

